01 / Vendor Profile
LEIDOS BIOMEDICAL RESEARCH, INC. Federal Contracts and Awards
UEI HV8BH9BPG8Y9 · CAGE 3LYK6
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $6.48B in net contract obligations to LEIDOS BIOMEDICAL RESEARCH, INC. across 1,525 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
LEIDOS BIOMEDICAL RESEARCH, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$779.39M
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $1.16B | 180 | 1 | — |
| FY 2021 | $934.67M | 225 | 1 | −19.2% |
| FY 2022 | $981.69M | 252 | 1 | +5.0% |
| FY 2023 | $1.20B | 236 | 1 | +22.5% |
| FY 2024 | $869.31M | 231 | 1 | −27.7% |
| FY 2025 | $559.56M | 229 | 1 | −35.6% |
| FY 2026 | $779.39M | 172 | 1 | +39.3% |
04 / Federal Customers
Which federal agencies buy from LEIDOS BIOMEDICAL RESEARCH, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $6.48B | 1,525 | 100.0% |
05 / Contracting Offices
Which contracting offices buy from LEIDOS BIOMEDICAL RESEARCH, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $6.48B | 1,525 | 100.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $4.27B | 962 | 1 | 65.8% |
| M1HA | OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES | $2.17B | 548 | 1 | 33.5% |
| M181 | OPER OF GOVT R&D GOCO FACILITIES | $43.36M | 13 | 1 | 0.7% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $0 | 2 | 1 | 0.0% |
08 / Competition Pattern
How was LEIDOS BIOMEDICAL RESEARCH, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for LEIDOS BIOMEDICAL RESEARCH, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N91025F00016 | Sep 30, 2026 | $342.19M | NATIONAL INSTITUTES OF HEALTH NIH NCI | 541715 | AN12 |
10 / Interpreting the Profile
How should you evaluate LEIDOS BIOMEDICAL RESEARCH, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.